HCG – Strand Life Sciences launch StrandAdvantage500 to broaden patient access to genomic testing
Based on the comprehensive genomic profiling approach which detects multiple actionable cancer biomarkers at ‘one go’ to optimise treatment for better clinical outcomes
The post HCG – Strand Life Sciences launch StrandAdvantage500 to broaden patient access to genomic testing appeared first on Express Healthcare.